Skip to content

Clinical trials

Phase 3 Opioid-Related Disorders trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Opioid-Related Disorders Phase: Phase 3 Country / region: United States Clear all

75 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20013
20032
20052
20064
20074
20082
20093
20103
20121
20134
20142
20157
20163
20174
20192
20202
20213
20234
20246
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed52
Recruiting8
Active, not recruiting5
Terminated4
Not yet recruiting3
Withdrawn3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Titan Pharmaceuticals6
University of California, Los Angeles6
Butler Hospital5
New York State Psychiatric Institute5
Yale University5
Friends Research Institute, Inc.4
Alkermes, Inc.3
Indivior Inc.3
BioDelivery Sciences International2
Braeburn Pharmaceuticals2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Opioid-Related Disorders75
Substance-Related Disorders13
Chronic Pain5
Heroin Dependence5
Substance Withdrawal Syndrome4
Alcoholism2
Cocaine-Related Disorders2
Morphine Dependence2
Narcotic-Related Disorders2
Pain2

Trials

Showing 1 to 25 of 75. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.